Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma

Clinical trial NCT06030037 · WITHDRAWN

Trial details

NCT number: NCT06030037
Sponsor: Diwakar Davar
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

PD-1 Refractory Advanced Melanoma

Start date: 2025-03-11
Primary completion: 2029-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.